Results 11 to 20 of about 197,953 (330)
Biomarkers in Hereditary Angioedema [PDF]
Clinical Reviews in Allergy & Immunology, 2021 A biomarker is a defined characteristic measured as an indicator of normal, biologic, pathogenic processes, or biological responses to an exposure or intervention.
G. Porębski, M. Kwitniewski, A. Reshef
semanticscholar +4 more sources
Hereditary angioedema: Not an allergy
Indian Journal of Dermatology, 2012 Hereditary angioedema is a genetic disorder due to a deficiency or malfunction of C1 esterase inhibitor. We herein describe a case of 25-year-old male who presented with swelling over face since one day.
Sanjay Bhivgade +3 more
doaj +4 more sources
Treatment of Hereditary Angioedema. [PDF]
Journal of Investigational Allergology and Clinical Immunology, 2021 Hereditary angioedema due to C1-esterase inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease. In the last decade, new drugs and new indications for old drugs have played a role in the management of C1-INH-HAE.
T. Caballero
semanticscholar +3 more sources
New England Journal of Medicine, 2018 Copyright © 2020 Massachusetts Medical Society. Hereditary angioedema is a rare, potentially life-threatening disorder characterized by attacks of cutaneous and submucosal swelling.
Paula J Busse, Sandra C Christiansen
semanticscholar +2 more sources
Romanian Journal of Laboratory Medicine, 2021 Acquired angioedema due to C1-inhibitor deficiency is a very rare disorder that usually appears in patients with lymphoproliferative and/or autoimmune diseases.
Bara Noémi +3 more
doaj +1 more source
Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology
Advances in Therapy, 2023 Hereditary angioedema (HAE) is an autosomal dominant disorder caused by a mutation in the C1 esterase inhibitor gene. HAE affects 1/50,000 people worldwide. Three main types of HAE exist: type I, type II, and type III.
Evan S Sinnathamby +9 more
semanticscholar +1 more source
Clinical Case Reports, 2021 Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients.
Shimalee Andarawewa +1 more
doaj +1 more source
Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
Frontiers in Physiology, 2023 Hereditary angioedema (HAE) is characterized by recurrent localized edema in various organs, which can be potentially fatal. There are different types of hereditary angioedema, which include genetic deficiency of C1 inhibitor (C1-INH) and hereditary ...
S. Hintze +6 more
semanticscholar +1 more source
Inhibition of Prekallikrein for Hereditary Angioedema.
New England Journal of Medicine, 2022 BACKGROUND Hereditary angioedema is characterized by recurrent and unpredictable swellings that are disabling and potentially fatal. Selective inhibition of plasma prekallikrein production by antisense oligonucleotide treatment (donidalorsen) may reduce ...
Lauré M. Fijen +16 more
semanticscholar +1 more source